Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 178 participants.
Also called NCT02661451
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 178 participants
- Registry
-
NCT02661451
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Canada, Netherlands
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02661451. Randomized; no masking; primary purpose treatment. Start 2016-09 (actual); primary completion 2023-02-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- SAPIEN 3 THV
- Intervention (Biological)
- Optimal Heart Failure Therapy
- Lead sponsor
- Cardiovascular Research Foundation, New York
- Collaborator
- Cardialysis BV
- Collaborator
- Avania
Record details
- Record id
cardio:ct-nct02661451- Content hash
774f4d31a49a2fcca419e96be6d950df346526b406e7806561b3d9aceeecf029